Dallas, TX, United States of America

Douglas Lorang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Osteal Therapeutics, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Douglas Lorang: Innovator in Irrigation Technology

Introduction

Douglas Lorang is an accomplished inventor based in Dallas, TX (US). He has made significant contributions to the field of irrigation technology. His innovative approach has led to the development of a unique treatment delivery system that enhances fluid management in various applications.

Latest Patents

Lorang holds a patent for an irrigation system and methods of use. This patent describes a treatment delivery system that includes a fluid delivery system connected to both a first and a second fluid reservoir. The system is designed to direct a first fluid from the first reservoir to a treatment site while simultaneously directing a second fluid from the second reservoir to the same site. The control unit manages the fluid delivery process, which consists of multiple phases, ensuring a controlled delivery of fluids as needed.

Career Highlights

Douglas Lorang is currently associated with Osteal Therapeutics, Inc., where he applies his expertise in developing innovative solutions. His work focuses on improving treatment delivery systems, which can significantly impact various medical and agricultural applications.

Collaborations

Lorang collaborates with notable professionals in his field, including Robert C. Hutton and Jude Paganelli. These partnerships enhance the development and implementation of advanced irrigation technologies.

Conclusion

Douglas Lorang's contributions to irrigation technology exemplify the impact of innovative thinking in addressing complex challenges. His patent and ongoing work at Osteal Therapeutics, Inc. highlight his commitment to advancing treatment delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…